| 846- | Gra, | Cytotoxic effect of Annona muricata Linn leaves extract on Capan-1 cells |
| - | in-vitro, | NA, | Ca9-22 |
| 7338- | Gra, | Pharmacological Activities of Soursop (Annona muricata Lin.) |
| - | Review, | Var, | NA |
| 7337- | Gra, | Synergistic interactions among flavonoids and acetogenins in Graviola (Annona muricata) leaves confer protection against prostate cancer |
| - | in-vitro, | Pca, | NA |
| 7336- | Gra, | In Vitro Evaluation of Annona muricata Leaf Infusion as a Modulator of Antineoplastic Drug-Induced Cytotoxicity in Cancer Cell Lines |
| - | in-vitro, | BC, | MDA-MB-231 |
| 7335- | Gra, | Effect of Annona muricata (Soursop) on Patients with Cancer: A Systematic Review |
| - | Review, | Var, | NA |
| 7334- | Gra, | Annonaceae Consumption Worsens Disease Severity and Cognitive Deficits in Degenerative Parkinsonism |
| - | in-vivo, | Park, | NA |
| 1234- | Gra, | Graviola attenuates DMBA-induced breast cancer possibly through augmenting apoptosis and antioxidant pathway and downregulating estrogen receptors |
| - | in-vivo, | BC, | NA |
| 1233- | Gra, | THERAPEUTIC ELIGIBILITY OF GRAVIOLA VERSUS 5-FLUOROURACIL: APOPTOTIC EFFICACY ON HEAD AND NECK SQUAMOUS CELL CARCINOMA AND NORMAL EPITHELIUM CELLS |
| - | in-vitro, | HNSCC, | NA |
| 1232- | Gra, | Graviola: A Systematic Review on Its Anticancer Properties |
| - | Review, | NA, | NA |
| 2437- | Gra, | Graviola inhibits hypoxia-induced NADPH oxidase activity in prostate cancer cells reducing their proliferation and clonogenicity |
| - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | 22Rv1 | - | in-vitro, | Pca, | PC3 | - | in-vitro, | Nor, | PWR-1E |
| 2438- | Gra, | Emerging therapeutic potential of graviola and its constituents in cancers |
| - | Review, | Var, | NA |
| 7332- | GSE, | The impact of grape seed extract treatment on blood pressure changes: A meta-analysis of 16 randomized controlled trials |
| - | Review, | Nor, | NA |
| - | Review, | Nor, | NA |
| 7331- | GSE, | Protection against drug- and chemical-induced multiorgan toxicity by a novel IH636 grape seed proanthocyanidin extract |
| - | in-vivo, | Nor, | NA |
| 7330- | GSE, | Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention |
| - | Review, | Var, | NA |
| - | Trial, | Nor, | NA |
| 7327- | GSE, | Dietary-feeding of grape seed extract prevents azoxymethane-induced colonic aberrant crypt foci formation in fischer 344 rats |
| - | in-vivo, | CRC, | NA |
| 7326- | GSE, | LEUCOSELECT PHYTOSOME MODULATES SERUM EICOSAPENTAENOIC ACID, DOCOSAHEXAENOIC ACID and PROSTAGLANDIN E3 IN A PHASE 1 LUNG CANCER CHEMOPREVENTION STUDY |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H520 |
| 7325- | GSE, | The Effects of a Grape Seed Procyanidin Extract on Cytochrome P450 3A4 Activity and Inflammatory Mediators in the Lungs of Heavy Active and Former Smokers |
| - | in-vitro, | Lung, | NA |
| 7324- | GSE, | A Pilot Study of a Grape Seed Procyanidin Extract for Lung Cancer Chemoprevention |
| - | Trial, | Lung, | NA |
| 7323- | GSE, | Grape seed procyanidin extract against lung cancer: the role of microrna-106b, bioavailability, and bioactivity |
| - | vitro+vivo, | Lung, | NA |
| 7322- | GSE, | MicroRNA-19a/b mediates grape seed procyanidin extract-induced anti-neoplastic effects against lung cancer |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Lung, | H520 | - | in-vitro, | Lung, | H1299 | - | in-vitro, | Nor, | BEAS-2B |
| 7329- | GSE, | Grape Seed Extract Positively Modulates Blood Pressure and Perceived Stress: A Randomized, Double-Blind, Placebo-Controlled Study in Healthy Volunteers |
| - | Trial, | Nor, | NA |
| 1118- | GSE, | Grape Seed Proanthocyanidins Inhibit Migration and Invasion of Bladder Cancer Cells by Reversing EMT through Suppression of TGF- β Signaling Pathway |
| - | in-vitro, | Bladder, | T24/HTB-9 | - | in-vitro, | Bladder, | 5637 |
| 1241- | GSE, | PACs, | Grape seed proanthocyanidins inhibit angiogenesis via the downregulation of both vascular endothelial growth factor and angiopoietin signaling |
| - | in-vitro, | Nor, | NA |
| 1240- | GSE, | PACs, | Grape Seed Proanthocyanidins Inhibit Melanoma Cell Invasiveness by Reduction of PGE2 Synthesis and Reversal of Epithelial-to-Mesenchymal Transition |
| - | in-vitro, | Melanoma, | A375 | - | in-vitro, | Melanoma, | Hs294T |
| 1292- | GSE, | EGCG, | Antiproliferative and Apoptotic Effects Triggered by Grape Seed Extract (GSE) versus Epigallocatechin and Procyanidins on Colon Cancer Cell Lines |
| - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | CRC, | HCT8 |
| 6561- | GSL, | Geraniol Pharmacokinetics, Bioavailability and Its Multiple Effects on the Liver Antioxidant and Xenobiotic-Metabolizing Enzymes |
| - | in-vivo, | Nor, | NA |
| 7134- | GSL, | Phase I study of oral spirogermanium |
| - | Trial, | NA, | NA |
| 7111- | GSL, | In vitro antiinflammatory activity of a new sesquiterpene lactone isolated from Siegesbeckia glabrescens |
| - | NA, | Nor, | NA |
| 30- | GSL, | A sesquiterpene lactone from Siegesbeckia glabrescens suppresses Hedgehog/Gli-mediated transcription in pancreatic cancer cells |
| - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | AsPC-1 |
| 108- | GSL, | A sesquiterpene lactone from Siegesbeckia glabrescens suppresses Hedgehog/Gli-mediated transcription in pancreatic cancer cells |
| - | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | AsPC-1 | - | in-vitro, | PC, | C3H10T1/2 |
| 2511- | H2, | Molecular hydrogen suppresses glioblastoma growth via inducing the glioma stem-like cell differentiation |
| - | in-vivo, | GBM, | U87MG |
| 2525- | H2, | Hydrogen-Rich Saline Attenuates Cardiac and Hepatic Injury in Doxorubicin Rat Model by Inhibiting Inflammation and Apoptosis |
| - | in-vivo, | NA, | NA |
| 2524- | H2, | Protective effect of hydrogen-rich water on liver function of colorectal cancer patients treated with mFOLFOX6 chemotherapy |
| - | Trial, | NA, | NA |
| 2523- | H2, | Prospects of molecular hydrogen in cancer prevention and treatment |
| - | Review, | Var, | NA |
| 2522- | H2, | A Systematic Review of Molecular Hydrogen Therapy in Cancer Management |
| - | Review, | Var, | NA |
| 2521- | H2, | Oxyhydrogen Gas: A Promising Therapeutic Approach for Lung, Breast and Colorectal Cancer |
| - | Review, | CRC, | NA | - | Review, | Lung, | NA | - | Review, | BC, | NA |
| 2520- | H2, | The Impact of Molecular Hydrogen on Mitochondrial ROS and Apoptosis in Colorectal Cancer Cells |
| - | in-vitro, | CRC, | NA |
| 2519- | H2, | Hydrogen: an advanced and safest gas option for cancer treatment |
| - | Review, | Var, | NA |
| 2518- | H2, | Hydrogen Therapy Reverses Cancer-Associated Fibroblasts Phenotypes and Remodels Stromal Microenvironment to Stimulate Systematic Anti-Tumor Immunity |
| - | in-vitro, | BC, | 4T1 | - | in-vitro, | Nor, | 3T3 |
| 2517- | H2, | Molecular Hydrogen Enhances Proliferation of Cancer Cells That Exhibit Potent Mitochondrial Unfolded Protein Response |
| - | in-vitro, | Var, | A549 | - | in-vitro, | NA, | HCT116 | - | in-vitro, | NA, | HeLa | - | in-vitro, | NA, | HepG2 | - | in-vitro, | NA, | HT1080 | - | in-vitro, | NA, | PC3 | - | in-vitro, | NA, | SH-SY5Y |
| 2516- | H2, | Hydrogen Gas in Cancer Treatment |
| - | Review, | Var, | NA |
| 2515- | H2, | Recent Advances in Studies of Molecular Hydrogen against Sepsis |
| - | Review, | Sepsis, | NA |
| 2514- | H2, | Hydrogen: A Novel Option in Human Disease Treatment |
| - | Review, | NA, | NA |
| 2513- | H2, | Hydrogen therapy: from mechanism to cerebral diseases |
| - | Review, | Stroke, | NA |
| 2512- | H2, | Hydrogen Attenuates Allergic Inflammation by Reversing Energy Metabolic Pathway Switch |
| - | in-vivo, | Asthma, | NA |
| 2510- | H2, | Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals |
| - | in-vivo, | Stroke, | NA |
| 2509- | H2, | Hydrogen inhibits endometrial cancer growth via a ROS/NLRP3/caspase-1/GSDMD-mediated pyroptotic pathway |
| - | in-vitro, | Endo, | AN3CA | - | in-vivo, | Endo, | NA |
| 2508- | H2, | Molecular hydrogen is a promising therapeutic agent for pulmonary disease |
| - | Review, | Var, | NA | - | Review, | Sepsis, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid